What is the dosage and treatment duration for Bactrim DS (trimethoprim/sulfamethoxazole) for urinary tract infections and skin infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bactrim DS Dosing for Urinary Tract and Skin Infections

Urinary Tract Infections

For uncomplicated UTIs in women, use Bactrim DS (160 mg trimethoprim/800 mg sulfamethoxazole) one tablet twice daily for 3 days. 1

Women with Uncomplicated Cystitis

  • Standard regimen: 1 double-strength tablet (160/800 mg) twice daily for 3 days 1
  • Clinical cure rates reach 90-100% when organisms are susceptible 1
  • Bacterial eradication rates are 91-100% for susceptible pathogens 1
  • Each additional day beyond 3 days increases adverse event risk by 5% without added benefit 1

Men with UTI

  • Require longer duration: 1 double-strength tablet (160/800 mg) twice daily for 7-14 days 1, 2
  • The 3-day regimen used in women is inadequate for male patients 2
  • Male UTIs are considered complicated and demand extended therapy 2

Pyelonephritis

  • Use 1 double-strength tablet twice daily for 14 days, only if susceptibility is confirmed 1

Critical Resistance Threshold

  • Only use Bactrim empirically when local E. coli resistance is <20% 1
  • When resistance exceeds 20%, treatment failures outweigh benefits 1
  • Cure rates drop from 84% (susceptible organisms) to 41% (resistant organisms) 1

When to Avoid Bactrim

  • Recent trimethoprim-sulfamethoxazole use in preceding 3-6 months 1
  • Travel outside the United States in preceding 3-6 months 1
  • Last trimester of pregnancy 1, 2
  • Local resistance data showing >20% E. coli resistance 1

Renal Dose Adjustments

  • CrCl >30 mL/min: Standard dose (1 DS tablet twice daily) 3
  • CrCl 15-30 mL/min: Half-dose (1 single-strength tablet or half DS tablet) 3
  • CrCl <15 mL/min: Use not recommended 3
  • Monitor electrolytes regularly as trimethoprim causes hyperkalemia 2
  • Ensure adequate hydration (at least 1.5 liters daily) to prevent crystalluria 2

Skin Infections

The FDA label does not provide specific dosing for skin infections. 3 For skin and soft tissue infections, standard adult dosing would follow the general UTI dosing pattern of 1 double-strength tablet twice daily, though duration would depend on infection severity and clinical response. 3

Alternative First-Line Agents

When Bactrim cannot be used due to resistance or contraindications:

  • Nitrofurantoin 100 mg twice daily for 5 days (90% clinical cure rate) 1
  • Fosfomycin 3g single dose 2
  • Pivmecillinam 400 mg three times daily for 3-5 days 2
  • These alternatives maintain resistance rates generally below 10% across all regions 1

Common Pitfalls to Avoid

  • Do not use 3-day regimens in men—this is inadequate treatment and a common error 2
  • Do not fail to adjust dose when CrCl <30 mL/min—this significantly increases toxicity risk 2, 3
  • Do not use empirically without checking local resistance patterns—hospital antibiograms often overestimate community resistance 1
  • Do not prescribe in last trimester of pregnancy 1, 2

References

Guideline

Uncomplicated Urinary Tract Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Urinary Tract Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.